ÂÜÀòÂÒÂ×

Dr. Jonathan Schoenfeld is an Associate Professor at Harvard Medical School and a Senior Physician at the Dana-Farber Cancer Institute. He serves as the Radiation Oncology Director of the Melanoma and Head and Neck Disease Centers at the Dana-Farber Cancer Institute and is a member of Cancer Immunology Program at the Dana-Farber/Harvard Cancer Center. He also serves as the Associate Director of Clinical Research within the Department of Radiation Oncology at Dana-Farber/Brigham and Women’s Cancer Center. He received his medical degree from the Harvard-MIT Division of Health Sciences and Technology at Harvard Medical School after completing a research fellowship as a Gates Scholar at the University of Cambridge in the UK. He performed his internship at Memorial Sloan Kettering Cancer Center, completed residency in radiation oncology in the Harvard Radiation Program and received a Master of Public Health in Clinical Effectiveness from the Harvard T.H. Chan School of Public Health. He has served on the NCI Radiation and Immune Modulation Working Group and the Radiation Developmental Therapeutics Subcommittee for NRG oncology. His research focuses on translational immunology and investigating the combination of novel therapeutic agents with radiotherapy.